Samuel J. Reich is Chairman at SAB Biotherapeutics, Inc. (SABS). They have made 3 open-market trades across 2 companies since 2021, most recently 2023-11-29.
CIK 0001394645
3 open-market purchases totalling $4.2M since 2021, never a sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.